A clinician's guide to hereditary colon cancer

Cancer Journal

Volumn 10, Issue 5, 2004, Pages 280-287

  Matloff, Ellen T ^a,b   Brierley, Karina L ^a,b   Chimera, Christina M ^a,b  

^a Yale University ^*

^b YALE CANCER CENTER   (United States)

Author keywords

Colon cancer; Colorectal cancer; Genetic counseling; Genetic testing

Indexed keywords

ADENOMATOUS POLYP; CANCER EPIDEMIOLOGY; CANCER RISK; COLON CANCER; FAMILIAL CANCER; FAMILY HISTORY; GENETIC COUNSELING; HUMAN; MUTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYMPTOMATOLOGY; COLON POLYPOSIS; COLORECTAL TUMOR; GENETIC SCREENING; GENETICS; PEUTZ JEGHERS SYNDROME;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; PEUTZ-JEGHERS SYNDROME;

EID: 16644377139     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200409000-00002     Document Type: Review

References (60)

1. Ries L, Eisner M, Kosary C. SEER cancer statistics review, 1973-1998. Bethesda (MD): National Cancer Institute 2001:1-21.
2. Jemal A, Murray T, Samuels A. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
3. Calvert P, Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002;137:603-612.
4. King J, Dozois R, Lindor N et al. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 2000;75:57-67.
5. Schneider K. Counseling About Cancer: Strategies for Genetic Counseling, 2nd ed. New York: Wiley-Liss, 2002.
6. Hernegger G, Harvey G, Guillem J. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002;45:127-136.
7. Qualman S, Bowen J, Erdman S. Molecular basis of the brain tumor-polyposis (Turcot) syndrome. Pediatr Dev Pathol 2003;6:574-576.
8. Sieber O, Lipton L, Crabtree M. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-799.
9. Lynch H, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-932.
10. Markey K, Axel L, Ahnen D. Basic concepts for genetic testing in common hereditary colorectal cancer syndromes. Curr Gastroenterol Rep 2002;4:404-413.
11. Katballe N, Juul S, Christensen M. Patient accuracy of reporting on hereditary nonpolyposis colorectal cancer-related malignancy in family members. Br J Surg 2001;88:1228-1233.
12. Stopfer J. Genetic counseling and clinical cancer genetics services. Semin Surg Oncol 2000;18:347-357.
13. Severin M. Hereditary cancer litigation: a status report. Oncology 1996;10:211-214.
14. Dunlop M. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002;51:v21-v27.
15. Trimbath J, Giardello F. Review article: genetic testing and counseling for hereditary colorectal cancer. Aliment Pharmacol Ther 2002;16:1843-1857.
16. Foulkes W. A tale of four syndromes: familial adenomatous polyposis, Garnder syndrome, attenuated APC and Turcot syndrome. QJM 1995;88:853-863.
17. Fearnhead N, Britton M, Bodmer W. The ABC of APC. Hum Mol Genet 2001;10:721-733.
18. Peters J. Familial cancer risk part 1: impact on todays oncology practice. J Oncol Manage 1994;3:18-30.
19. Powell S, Petersen G, Krush A. Molecular diagnosis in familial adenomatous polyposis. N Engl J Med 1993;329:1982-1987.
20. Knudsen A, Bisgaard M, Bulow S. Attenuated familial adenomatous polyposis (AFAP): a review of the literature. Fam Cancer 2003;2:43-55.
21. Soravia C, Berk T, Madlensky L. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998;62:1290-1301.
22. Hamilton S, Liu B, Parsons R. The molecular basis of Turcot's syndrome: a review. N Engl J Med 1995;332:839-847.
23. Paraf F, Jothy S, Van Meir E. Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol 1997;15:2744-2758.
24. Ivanovich J, Whelan A. Cancer and Peutz-Jeghers syndrome: a review. J Genet Couns 1997;6:193-206.
25. Giardiello F, Brensinger J, Tersmette A. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-1453.
26. Eng C. Cowden syndrome. J Genet Couns 1997;6:181-192.
27. Zhou X-P, Woodford-Richens K, Lehtonen R. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 2001;69:704-711.
28. Lynch H, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). Cancer 1996;78:1149-1167.
29. Lynch H, Smyrk T. An update on Lynch syndrome. Curr Opin Oncol 1998;10:349-356.
30. Lynch H, Smyrk T. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 1998;338:1537-1538.
31. Brown G, St. John D, Macrae F. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol 2001;80:346-349.
32. Aarnio M, Mecklin J-P, Aaltonen L. Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430-433.
33. Hall N, Williams M, Murday V. Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet 1994;31:627-631.
34. Schwartz R, Torre D. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995;33:90-104.
35. Kruse R, Rutten A, Lamberli C. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer. Am J Hum Genet 1998;63:63-70.
36. Lin K, Shashidharan M, Ternent C. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Col Rectum 1998;41:428-433.
37. Lin K, Shashidharan M, Thorson A. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998;2:67-71.
38. Scott R, McPhillips M, Meldrum C. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001;68:118-127.
39. Muller A, Edmonston T, Corao D. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 2002;62:1014-1019.
40. Vasen H, Morreau H, Nortier J. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001;68:1533-1534.
41. Vasen H, Mecklin J-P, Meera Khan P. The International Collaborative Group on hereditary non-polyposis colorectal cancer. Dis Col Rectum 1991;34:424-425.
42. Vasen H, Watson P, Mecklin J et al. New criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) pre-disposed by the International Collaborative Group on HNPCC (ICG-HNPCC). Gastroenterology 1999;116:1453-1456.
43. American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer genetic testing. Gastroenterology 2001;121:195-197.
44. de la Chapelle A. Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out. J Clin Oncol 2002;20:897-899.
45. Lindor N, Burgart L, Leontovich O. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043.
46. Umar A, Boland C, Terdiman P. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-268.
47. Reyes C, Allen B, Terdiman J. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma. Cancer 2002;95:1848-1856.
48. Scartozzi M, Bianchi F, Rosati S. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 2002;20:1203-1208.
49. Wu Y, Berends M, Mensink R. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999;65:1291-1298.
50. Ribic C, Sargent D, Moore M. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-adjuvant chemotherapy for colon cancer. N Engl J Med 2003;95:2422.
51. de la Chapelle A. Microsatellite instability. N Engl J Med 2003;349:209-210.
52. Chiaravalli A, Furlan D, Facco C. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch 2001;438:39-48.
53. Wahlberg S, Schmeits J, Thomas G. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germline MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002;62:3485-3492.
54. Christensen M, Katballe N, Wikman F. Anti-body based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 2002;95:2422-2430.
55. Shappell H, Matloff E. Writing effective insurance justification letters for cancer genetic testing: a streamlined approach. J Genet Couns 2001;10:331-341.
56. Laken S, Petersen G, Gruber S. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83.
57. Gryfe R, Nicola N, Lal G et al. Inherited colorectal polyposis and cancer risk of the APC11307K polymorphism. Am J Hum Genet 1999;64:378-384.
58. Gruber S, Petersen G, Kinzler K et al. Cancer, crash sites, and the new genetics of neoplasia. Gastroenterology 1999;116:210-212.
59. Giardiello F, Brensinger J, Petersen G. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-827.
60. Batra S, Valdimarsdottir HB, McGovern M et al. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol 2002;97:729-733.